Literature DB >> 18211631

Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus.

Jaime S Rosa1, Rebecca L Flores, Stacy R Oliver, Andria M Pontello, Frank P Zaldivar, Pietro R Galassetti.   

Abstract

OBJECTIVE: An imbalance of pro-/anti-inflammatory cytokines may accelerate diabetic vascular complications and interfere with proper wound healing. Currently, limited available literature suggests that plasma concentrations of certain pro- and anti-inflammatory cytokines may be altered during hyperglycemia/diabetes mellitus. It is still unclear, however, whether these concepts also apply to children with diabetes, and whether alterations in circulating cytokine levels are a permanent feature of diabetes or an acute effect of fluctuating glucose concentrations.
METHODS: Twenty-two children with type 1 diabetes mellitus (T1DM) were studied. In 13 children, postprandial morning plasma glucose was >11.1 mmol/L at least once (hyperglycemic group, or HyG group); in 9 subjects, plasma glucose never exceeded 10.6 mmol/L (non-hyperglycemic group, or non-HyG group). After admission, intensive euglycemia (5.0-6.1 mmol/L) was achieved in all participants via intravenous insulin and dextrose for at least 90 min. Blood samples were drawn every 30 min to determine plasma levels of 14 cytokines and chemokines.
RESULTS: Interleukin IL-1alpha, IL-4, and IL-6 were elevated in HyG group compared with non-HyG not only when plasma glucose was elevated but also during the first 2 h following return to euglycemia. The levels of the other 11 cytokines were not significantly different.
CONCLUSIONS: Specific cytokines (IL-1alpha, IL-4, and IL-6) are acutely elevated during hyperglycemia in children with T1DM, and these elevations persist for hours after hyperglycemia has been corrected. Therefore, aside from glycemic control, additional therapeutic measures against elevated proinflammatory signals may be necessary for preventing vascular complications in children with hyperglycemic diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211631     DOI: 10.1111/j.1399-5448.2007.00243.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  20 in total

1.  Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days.

Authors:  Jaime S Rosa; Rebecca L Flores; Stacy R Oliver; Andria M Pontello; Frank P Zaldivar; Pietro R Galassetti
Journal:  J Appl Physiol (1985)       Date:  2009-12-10

Review 2.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

3.  C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia.

Authors:  Jaime Haidet; Vincenza Cifarelli; Massimo Trucco; Patrizia Luppi
Journal:  Inflamm Res       Date:  2011-09-27       Impact factor: 4.575

4.  Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study.

Authors:  Janet K Snell-Bergeon; Nancy A West; Elizabeth J Mayer-Davis; Angela D Liese; Santica M Marcovina; Ralph B D'Agostino; Richard F Hamman; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2010-04-06       Impact factor: 5.958

5.  Altered kinetics of interleukin-6 and other inflammatory mediators during exercise in children with type 1 diabetes.

Authors:  Jaime S Rosa; Stacy R Oliver; Masato Mitsuhashi; Rebecca L Flores; Andria M Pontello; Frank P Zaldivar; Pietro R Galassetti
Journal:  J Investig Med       Date:  2008-04       Impact factor: 2.895

6.  Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

Authors:  Christian Hundhausen; Alena Roth; Elizabeth Whalen; Janice Chen; Anya Schneider; S Alice Long; Shan Wei; Rebecca Rawlings; MacKenzie Kinsman; Stephen P Evanko; Thomas N Wight; Carla J Greenbaum; Karen Cerosaletti; Jane H Buckner
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

7.  Circulating levels of interleukin-1 family cytokines in overweight adolescents.

Authors:  Christian Jung; Norbert Gerdes; Michael Fritzenwanger; Hans Reiner Figulla
Journal:  Mediators Inflamm       Date:  2010-02-09       Impact factor: 4.711

8.  Ex vivo TCR-induced leukocyte gene expression of inflammatory mediators is increased in type 1 diabetic patients but not in overweight children.

Authors:  Jaime S Rosa; Masato Mitsuhashi; Stacy R Oliver; Mieko Ogura; Rebecca L Flores; Andria M Pontello; Pietro R Galassetti
Journal:  Diabetes Metab Res Rev       Date:  2010-01       Impact factor: 4.876

Review 9.  Inflammation and neuropeptides: the connection in diabetic wound healing.

Authors:  Leena Pradhan; Christoph Nabzdyk; Nicholas D Andersen; Frank W LoGerfo; Aristidis Veves
Journal:  Expert Rev Mol Med       Date:  2009-01-13       Impact factor: 5.600

10.  Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing.

Authors:  Leena Pradhan; Xuemei Cai; Szuhuei Wu; Nicholas D Andersen; Michelle Martin; Junaid Malek; Patrick Guthrie; Aristidis Veves; Frank W Logerfo
Journal:  J Surg Res       Date:  2009-10-23       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.